Answer
Aug 04, 2026 - 11:18 AM
Tagrisso is used to treat adult patients with non-small cell lung cancer (NSCLC) who have specific mutations in the EGFR gene, such as exon 19 deletions or exon 21 L858R mutations. This targeted approach ensures that the medication works effectively on cancer cells with these mutations, which provides a more personalized and effective cancer treatment.
